Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

171379 Press Releases
DateTitleCompany
27 Jun 17 Nuvaira Announces Enrollment Completion in First Sham-Controlled Clinical Trial of Targeted Lung Denervation for COPD Nuvaira, Inc,
Published by
GlobeNewswire
27 Jun 17 Bavarian Nordic Announces Positive Data from Ongoing Phase 2 Study Investigating a Universal RSV Vaccine Bavarian Nordic A/S,
Published by
GlobeNewswire
27 Jun 17 Home Run! Alex Rodriguez Goes To Bat For TruFusion TruFusion,
Published by
PR Newswire
27 Jun 17 ORIG3N™ Closes Latest Round of Funding; Welcomes New Board Member and New Investor ORIG3N, Inc.,
Published by
PR Newswire
27 Jun 17 New Research Reveals Policies That Support Access to Breastfeeding Counseling and Supplies Have High Rewards, Low Cost Medela,
Published by
PR Newswire
27 Jun 17 Magnum™ Large Size Condoms Partners with the Compound to Release Exclusive Music Featuring Fabolous and PnB Rock Magnum Condoms,
Published by
PR Newswire
27 Jun 17 Former LA County Sheriff Deputy and Youth Worker Appointed to Mental Health Watchdog CCHR International,
Published by
PR Newswire
27 Jun 17 Canada Radiosurgery Market Outlook to 2023 Reportlinker,
Published by
PR Newswire
27 Jun 17 Zipnosis And Healthcare Leaders Form Clinical Quality Advisory Council To Establish Virtual Care Standards Zipnosis,
Published by
PR Newswire
27 Jun 17 Chromocell Announces Initiation of Multiple Ascending Doses Portion of Phase 1 Clinical Trial Chromocell Corporation,
Published by
PR Newswire
27 Jun 17 Lecturio Reaches Major Milestone in Its Quest to Help World Produce More and Better Doctors Lecturio GmbH,
Published by
PR Newswire
27 Jun 17 Windsor Palms Care Center of Artesia Completes First-Ever End-of-Life Certification Course Windsor Palms Care Center of Artesia,
Published by
PR Newswire
27 Jun 17 Dance Biopharm Appoints Steve Thornton to Board of Directors Dance Biopharm,
Published by
PR Newswire
27 Jun 17 Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins Selexis SA,
Published by
Business Wire
27 Jun 17 Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors Halo Pharma,
Published by
Business Wire
27 Jun 17 Crestovo Doses Patients in PRISM 3, a Clinical Trial of CP101, a Microbiome Therapy for the Prevention of Recurrent Clostridium difficile Infection Crestovo,
Published by
Business Wire
27 Jun 17 InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Thomas Jefferson University Hospital InVivo Therapeutics Holdings Corp.,
Published by
Business Wire
27 Jun 17 Regenacy Pharmaceuticals Appoints Simon S. Jones as President and Chief Executive Officer Regenacy Pharmaceuticals, LLC,
Published by
Business Wire
27 Jun 17 Oncolytics Biotech® Inc. Opens U.S. Based Office in San Diego Oncolytics Biotech Inc.,
Published by
PR Newswire
27 Jun 17 ZanthoSyn Now Available on GNC.com Cardax, Inc.,
Published by
Business Wire
27 Jun 17 NantCell, a NantWorks Company, to Acquire Altor BioScience NantCell, Inc.,
Published by
Business Wire
27 Jun 17 DNAnexus Launches Novel Platform for Human Microbiome Research DNAnexus, Inc.,
Published by
Business Wire
27 Jun 17 Cerulean Urges Stockholders to Vote for Proposals at July 19, 2017 Special Stockholder Meeting Cerulean Pharma Inc.,
Published by
Business Wire
27 Jun 17 Teva and Xenon Announce Phase II Study of Topical TV-45070 in Patients with Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc.,
Published by
Business Wire
27 Jun 17 Three Day Programme: Drafting Commercial Contracts for the Pharmaceutical Industry (London, United Kingdom - November 20-21-22, 2017) - Research and Markets Research and Markets,
Published by
Business Wire
27 Jun 17 Global Vasculitis Treatment Market to Grow at a CAGR of 4.2% 2017-2021: Key Vendors are Bristol-Myers Squibb, Celgene, F. Hoffmann-La Roche & GlaxoSmithKline - Research and Markets Research and Markets,
Published by
Business Wire
27 Jun 17 TP Therapeutics Announces FDA Orphan Drug Designation Granted to TPX-0005 for Treatment of Non-Small Cell Lung Adenocarcinomas Harboring ALK, ROS1, or NTRK Oncogenic Rearrangements TP Therapeutics, Inc.,
Published by
Business Wire
27 Jun 17 RaNA Therapeutics Relaunches as Translate Bio to Advance RNA Therapeutics Translate Bio,
Published by
Business Wire
27 Jun 17 Ra Pharmaceuticals Announces Initial Data from Phase 2 Clinical Trial of RA101495 in PNH Ra Pharmaceuticals, Inc.,
Published by
Business Wire
27 Jun 17 Axial Biotherapeutics to Host Workshop Highlighting Advances in Gut Microbiome-Brain Connections Axial Biotherapeutics,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.